,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-09-26 03:01:00,"Veeva Systems Inc. (NYSE: VEEV) stock isn't too far away from doubling in 2018, with over three months remaining in the year.",0.8589951395988464,0.03659900650382042,0.10440593957901001,positive,0.8223961591720581
1,2018-09-26 03:01:00,Shares of the life sciences cloud solutions provider are at all-time highs with no end in sight to its momentum.,0.8433862328529358,0.0485367625951767,0.10807707160711288,positive,0.7948494553565979
2,2018-09-26 03:01:00,But is Veeva Systems still a buy?,0.10000837594270706,0.03906542807817459,0.8609261512756348,neutral,0.06094294786453247
3,2018-09-26 03:01:00,"As you might expect with a stock that skyrocketed so much so quickly, there are arguments both for and against Veeva.",0.058933112770318985,0.4279400110244751,0.5131268501281738,neutral,-0.3690069019794464
4,2018-09-26 03:01:00,The strongest case for buying Veeva Systems is that the company's long-term growth prospects remain very good.,0.8744405508041382,0.011958912014961243,0.11360058933496475,positive,0.8624816536903381
5,2018-09-26 03:01:00,"Like a sports team, businesses have to play both offense and defense.",0.019638365134596825,0.027488846331834793,0.9528728127479553,neutral,-0.007850481197237968
6,2018-09-26 03:01:00,Veeva looks great on both fronts.,0.29819416999816895,0.012957071885466576,0.6888487935066223,neutral,0.2852371037006378
7,2018-09-26 03:01:00,"Veeva's primary market has been and continues to be the life sciences industry, with a special focus on drugmakers.",0.022402705624699593,0.004767823964357376,0.9728294610977173,neutral,0.017634881660342216
8,2018-09-26 03:01:00,"However, the company is making nice progress in expanding beyond this core market.",0.9258590340614319,0.013074136339128017,0.06106686592102051,positive,0.9127848744392395
9,2018-09-26 03:01:00,"Veeva Systems CEO Peter Gassner noted in the company's Q2 earnings call that the company now has its ""first seven-figure customer"" outside of life sciences.",0.8689693808555603,0.01332517433911562,0.11770538985729218,positive,0.8556442260742188
10,2018-09-26 03:01:00,"Granted, it's still early for Veeva's foray into new industries.",0.5444675087928772,0.011021648533642292,0.44451087713241577,positive,0.5334458351135254
11,2018-09-26 03:01:00,"However, investors shouldn't ignore the potential for the company to establish a solid customer base outside of life sciences and then continue to grow its market share.",0.93499356508255,0.013642415404319763,0.0513639897108078,positive,0.9213511347770691
12,2018-09-26 03:01:00,The picture also looks really good for Veeva in its core market.,0.849985659122467,0.013016746379435062,0.13699758052825928,positive,0.8369688987731934
13,2018-09-26 03:01:00,"The company's newer products, including its electronic data capture (EDC) system for gathering clinical trials data electronically rather than via paper, provide a great opportunity for growth.",0.8741326928138733,0.012810016050934792,0.11305734515190125,positive,0.8613227009773254
14,2018-09-26 03:01:00,"As my Fool colleague Brian Stoffel noted recently , Veeva could also rejuvenate growth from its flagship customer relationship management (CRM) applications with its Nitro next-generation commercial data warehouse.",0.920036256313324,0.012436917051672935,0.06752689182758331,positive,0.9075993299484253
15,2018-09-26 03:01:00,"In addition, Veeva continues to be in a great position to hold onto its existing customers -- the equivalent of playing defense.",0.8782141208648682,0.012971489690244198,0.10881449282169342,positive,0.8652426600456238
16,2018-09-26 03:01:00,"The more new tools like Nitro that the company introduces, the ""stickier"" Veeva's products become to customers.",0.1691291481256485,0.030833112075924873,0.800037682056427,neutral,0.13829603791236877
17,2018-09-26 03:01:00,"Of course, even without new products, the costs and headaches of switching to another provider help boost Veeva's customer retention rates.",0.9490043520927429,0.01990632526576519,0.03108927421271801,positive,0.9290980100631714
18,2018-09-26 03:01:00,Probably no one would question Veeva's enviable position atop the cloud solutions market in the life sciences industry.,0.45032069087028503,0.05286559835076332,0.49681371450424194,neutral,0.397455096244812
19,2018-09-26 03:01:00,"However, probably no one would question that Veeva stock also trades at a steep premium.",0.1323443055152893,0.05608006939291954,0.8115756511688232,neutral,0.07626423239707947
20,2018-09-26 03:01:00,Veeva's shares currently trade at more than 100 times trailing-12-month earnings and at more than 61 times expected earnings.,0.08195290714502335,0.0057738847099244595,0.9122732281684875,neutral,0.07617902010679245
21,2018-09-26 03:01:00,"Those are nosebleed levels, for sure.",0.08402302116155624,0.10088341683149338,0.8150935769081116,neutral,-0.016860395669937134
22,2018-09-26 03:01:00,"Often when a stock has such a lofty valuation, supporters of the stock can point to growth prospects that make the valuation appear to be more attractive.",0.528853714466095,0.034196559339761734,0.4369497299194336,positive,0.49465715885162354
23,2018-09-26 03:01:00,But Veeva's price-to-earnings-to-growth (PEG) ratio of 3.56 is also really high.,0.5065189003944397,0.016903400421142578,0.4765776991844177,positive,0.4896154999732971
24,2018-09-26 03:01:00,"In large part because of this sky-high valuation, Wall Street analysts aren't all that positive about Veeva's near-term prospects.",0.053676579147577286,0.323707640171051,0.6226157546043396,neutral,-0.27003106474876404
25,2018-09-26 03:01:00,The consensus one-year price target for Veeva is 6% below the current share price.,0.0337064228951931,0.527645468711853,0.4386480748653412,negative,-0.49393904209136963
26,2018-09-26 03:01:00,Nearly half of the analysts covering Veeva rate it as a stock to hold rather than as one to buy.,0.0288678091019392,0.03722185641527176,0.9339103698730469,neutral,-0.008354047313332558
27,2018-09-26 03:01:00,There's also the reality that stocks with high earnings multiples often feel the brunt of an overall market pullback more than more attractively valued stocks do.,0.21806563436985016,0.35816481709480286,0.42376959323883057,neutral,-0.1400991827249527
28,2018-09-26 03:01:00,The current bull market is getting to be very long in the tooth.,0.1266469806432724,0.16194771230220795,0.7114052772521973,neutral,-0.03530073165893555
29,2018-09-26 03:01:00,My fellow Motley Fool contributor Sean Williams wrote a few weeks ago about several signs that a recession is closer than you might realize .,0.12190341204404831,0.3991233706474304,0.4789731800556183,neutral,-0.2772199511528015
30,2018-09-26 03:01:00,"If a recession comes, Veeva could fall -- and fall hard.",0.034956835210323334,0.9086858630180359,0.05635729432106018,negative,-0.8737290501594543
31,2018-09-26 03:01:00,"To buy or not to buy

If you're focused only on the short term and are afraid of a significant market pullback, staying away from Veeva might make sense.",0.05157865956425667,0.02975637838244438,0.9186649322509766,neutral,0.021822281181812286
32,2018-09-26 03:01:00,"However, for long-term investors, I think that Veeva remains a good pick even at its premium valuation.",0.7991870045661926,0.01702062226831913,0.1837923675775528,positive,0.7821663618087769
33,2018-09-26 03:01:00,It's important to keep in mind that Veeva's shares have traded at even higher earnings multiples in the past and the stock still moved higher.,0.8585422039031982,0.024873945862054825,0.11658386886119843,positive,0.8336682319641113
34,2018-09-26 03:01:00,Investors should also realize that Wall Street analysts tend to focus more on the near term than the long term.,0.1146189495921135,0.013528013601899147,0.8718530535697937,neutral,0.1010909378528595
35,2018-09-26 03:01:00,Few stocks enjoy the kind of competitive advantages that Veeva does in the life sciences industry.,0.2248000055551529,0.010370636358857155,0.7648293972015381,neutral,0.2144293636083603
36,2018-09-26 03:01:00,The potential for the company to expand into other industries beyond life sciences is icing on the cake.,0.7318984866142273,0.012593935243785381,0.2555074989795685,positive,0.7193045616149902
37,2018-09-26 03:01:00,"Although Veeva could be volatile because of its valuation, the future for this high-flying stock appears to be as bright as ever.",0.8719861507415771,0.014441431500017643,0.11357243359088898,positive,0.8575447201728821
38,2018-09-26 03:01:00,"10 stocks we like better than Veeva Systems

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.",0.12699975073337555,0.025114860385656357,0.8478853702545166,neutral,0.1018848866224289
39,2018-09-26 03:01:00,"After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has quadrupled the market.",0.8087436556816101,0.0373060368001461,0.15395022928714752,positive,0.7714376449584961
40,2018-09-26 03:01:00,"*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Veeva Systems wasn't one of them!",0.2355690747499466,0.014962825924158096,0.7494681477546692,neutral,0.2206062525510788
41,2018-09-26 03:01:00,That's right -- they think these 10 stocks are even better buys.,0.8146857619285583,0.02307075634598732,0.16224350035190582,positive,0.7916150093078613
42,2018-09-26 03:01:00,Click here to learn about these picks!,0.0694708302617073,0.055800698697566986,0.8747285008430481,neutral,0.01367013156414032
43,2018-09-26 03:01:00,Keith Speights has no position in any of the stocks mentioned.,0.009128669276833534,0.045183293521404266,0.9456880688667297,neutral,-0.03605462610721588
44,2018-09-26 03:01:00,The Motley Fool owns shares of and recommends Veeva Systems.,0.034477271139621735,0.013045232743024826,0.9524774551391602,neutral,0.02143203839659691
45,2018-09-26 03:01:00,The Motley Fool has a disclosure policy .,0.016547100618481636,0.017303917557001114,0.9661489725112915,neutral,-0.0007568169385194778
46,2018-09-26 03:01:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
